Toxic Shock Syndrome (TSS), a superantigen-mediated illness, is characterized by rash, hypotension and multi-organ dysfunction. Predictors of TSS and related morbidity and mortality are poorly defined. In this study, data on 61,959,084 hospitalizations from the 2003-2012 Nationwide Inpatient Sample, a 20% stratified sample of US hospitalizations, were analyzed and ICD-9-CM coding used to identify 4491 hospitalizations with a diagnosis of TSS. Incidence, in-hospital mortality rate, comorbidities, length of stay and costs of care attributable to TSS were determined. In multivariate survey logistic regression models, TSS was associated with female sex (adjusted odds ratio , and higher age. In conclusion, there are significant racial/ethnic, socioeconomic, and comorbid disparities in the incidence and mortality of TSS in adults and children in the USA.
TSS is a severe, systemic, inflammatory illness characterized by fever, rash, shock and multiorgan failure (1) . First reported in 1978, TSS is mediated by superantigen production during staphylococcal or streptococcal infection (2) (3) (4) . The incidence of TSS may have been increasing in recent years. Two recent metropolitan-and state-wide epidemiologic studies estimated the annual incidence of TSS to be 5.2 and 6.4 per million persons in the USA (5, 6) . The incidence of streptococcal TSS is less well-defined; however, the rate of invasive group A strep infections is approximately thirty per million persons annually (7, 8) , streptococcal TSS accounting for a small fraction of those cases. Only one study has examined the epidemiology of TSS in childhood and found the incidence to be 1.3 per million persons per year. (9) However, large scale studies that can be generalized to the entire USA population have not yet been performed, perhaps due to the rarity and complexity of the condition.
Though certain risk factors for and comorbidities of TSS, such as tampon use (10, 11) , recent nasal surgery and invasive group A strep infection, have been well-established (12) , sociodemographic factors, inpatient burden and disease comorbidities contributing to hospitalization and mortality attributable to TSS remain less well defined. The aim of this study was to describe the sociodemographic and comorbid factors leading to hospitalization and mortality attributable to TSS in adults and children in the USA. Additionally, the inpatient burden of TSS with respect to costs and LOS was investigated. We hypothesized that racial characteristics, age and socioeconomic disparities affect the diagnosis of TSS and that TSS is associated with dramatically higher than average cost of care and LOS than for other inpatients.
MATERIALS AND METHODS
A 20% stratified sample of all hospitalizations in the USA, excluding rehabilitation and long-term acute care hospitals, was abstracted from the 2003-2012 National Inpatient Sample (NIS) and analyzed. The NIS was developed by the Agency for Healthcare Research and Quality as part of the Healthcare Cost and Utilization Project. Each year of the NIS contains data on approximately 7 million hospitalizations, with sample weights created by the NIS that factor in the sampling designs of hospitals. Thus, it is possible to estimate prevalences that are generalizable to the entire cohort of hospital discharges in the USA. All data were de-identified and all discharges from sampled hospitals are included in the database.
Case and comorbidity identification
Hospital discharges with either a principal or secondary diagnosis of TSS were identified using the Ninth Revision of the ICD-9-CM code 040.82. In the NIS, the principal diagnosis is defined as the condition largely responsible for hospital admission. The structure of the NIS allows storage for a single principal diagnosis of no more than 24 secondary diagnoses and no more than 15 procedures associated with each hospitalization. The control group consisted of all hospitalizations without a diagnosis of TSS, excluding those for normal pregnancy/ delivery, yielding a cohort representative of hospitalizations in the USA.
Comorbidities and procedures were classified by ICD-9-CM coding and determined by the principal and secondary diagnoses and procedure codes. The diagnoses analyzed were chosen based on previouslydescribed associations with TSS or hypothesized contributions to hospitalization and mortality.
Mortality and loss of function
Both crude and age/sex adjusted inpatient mortality, based on the composition of the population of the USA from 2003-2012, were calculated. Patients who had been transferred to another acute-care hospital upon discharge were excluded from mortality rate determinations because such transfers may have represented escalation of care. Loss of function and mortality risk were determined by the All Patient Refined Diagnoses Related Group classification, which is determined on the basis of algorithms performed by software developed by the All Patient Refined Diagnoses Related Group (3M; Salt Lake City, UT, USA).
Statistical methods
All data processes and statistical analyses were performed using the SURVEY procedures of SAS version 9.4, allowing for adjustment for complex weighting, sample clusters and strata of NIS. The weighted incidence of hospitalizations with a diagnosis of TSS, excluding patients who had been transferred to another hospital, was determined. Mean, median, standard deviation and sum regarding LOS and costs of care were calculated. Costs of care were adjusted for inflation to the year 2014 according to the consumer price index and were based on the total charge of the hospitalization in combination with the cost-to-charge ratio provided by the Healthcare Cost and Utilization Project.
A number of associations of hospitalization, mortality, LOS and cost of care attributable to TSS were examined, including age, sex, hospital region, season, race, zip-code income quartile, urban location, number of chronic conditions, hospital size and hospital type. Survey logistic regression models were constructed with TSS as the dependent variable and each of the aforementioned covariates as the independent variable. To explore differences in risk factors between TSS and other causes of septic shock, logistic regression models in which the dependent TSS variable was compared against a control group of all septic shock cases were constructed. To determine if streptococcal and staphylococcal TSS have different risk factors, regression models in which the dependent staphylococcal TSS variable was compared against a streptococcal TSS control group were created. To determine predictors of mortality, a logistic regression model with stepwise selection was created in which the independent variables were all of the aforementioned sociodemographic and hospital characteristic plus each comorbidity examined and the dependent variable was inpatient death (yes/no). To determine predictors of LOS and cost of care, survey linear regression models were created with each sociodemographic characteristic as the independent variables and log-transformed LOS or cost of care as the dependent variables. Finally, analysis of variance was used to compare incidence and mortality rates for TSS over time and by cause of infection. Post-hoc comparisons were performed between 2003-2004, 2005-2006, 2007-2008, 2009-2010 , and 2011-2012 using Tukey's method.
Associations between each comorbidity and TSS hospitalization were examined in multivariate survey logistic regression models, with age, sex, and race as additional independent covariates. aORs with 95% confidence intervals were graphed on forest plots through Open Meta Analyst, an open-source application supported by Brown University and the Agency for Healthcare Research and Quality. Finally, the top 20 most frequent principal diagnoses in patients with a secondary discharge diagnosis of TSS were examined. Table S3 ).
RESULTS

Study characteristics
LOS and cost of care
The mean LOS of patients with TSS was 10.65 AE 0.23 days compared with 2.76 AE 0.007 days for patients without TSS. The mean cost of care for patients with TSS was dramatically higher than that of those without TSS ($36,656 AE 942 vs. $11,703 AE 88). The weighted total cost of care of patients hospitalized with TSS from 2003-2012 was $720,299,904.
In multivariate survey linear regression models, LOS was associated with male sex; age groups 40-59 and 60-79 years; black, Hispanic, Asian and other race/ethnicity; winter season; and more than one chronic condition. In turn, cost of care was associated with male sex; age groups 40-59 and 60-79 years; black, Hispanic, Asian and other race/ethnicity; the west region; and more than one chronic condition (P < 0.05 for all) ( Table 2) .
Comorbidities of patients with TSS
Overall, 29.4% of TSS patients were reported to have streptococcal infection (age, 40.3 AE 0.79 years [mean AE SD]; 54.1% female), whereas 32.5% had staphylococcal infections (32.0 AE 0.72 years, 63.8% female) of which 23.4% were identified as methicillin-sensitive Staphylococcal aureus and 3.7% as methicillin-resistant Staphylococcal aureus. Only 3.4% were reported to have both streptococcal and staphylococcal infection. Rates of streptococcal infection increased between 2003 and 2012 (anova, P ¼ 0.0007), whereas staphylococcal infection rates did not change significantly overall (P ¼ 0.30).
Only 8.0% (1714) of patients with TSS were reported to have vaginal foreign bodies (mean age, 25.0 AE 0.65 years); one patient had a nasal foreign body. Rates of vaginal foreign bodies associated with TSS did not change Table S4 ).
Hospital course and disposition
TSS patients underwent intubation and ventilation (27.3%), physical therapy (0.8%), incision and drainage (5.0%), skin debridement (7.5%), dialysis (8.6%) or dilation and curettage (0.4%) ( Table 3) . Upon discharge, patients with TSS most commonly went home or into self-care (60.0% [58.1-61.9%]) and less commonly were transferred to a short-term hospital (Table 3) .
Mortality
The crude mortality rate was 9.6% (8. (Table 4 ). In contrast, age 0-17 years (0.24 [0.17-0.35]), urinary tract infection, fall and summer seasons, streptococcal bacteremia, and any nutritional deficiency anemia were associated with decreased mortality in TSS patients.
Age-distribution and mortality in patients with TSS associated with vaginal foreign bodies
Because vaginal foreign body was the strongest predictor of TSS, the age and mortality distribution of patients with TSS associated with vaginal foreign bodies were more fully characterized. Vaginal foreign body was comorbid with TSS overwhelmingly in the 0-17 and 18-39 years age groups (1432 patients in all); however, none of these patients died (Supplemental Table S6 ). In addition, 244 patients were in the 40-59 years age group and 22 (9.0%) of them died.
DISCUSSION
In the present study, we identified approximately 21,465 patients with TSS from 2003 to 2012, the mean estimated annual incidence being 6.65 cases per million persons, which is slightly higher than that found in two recent studies (5.2 and 6.4 per million persons annually, respectively) (5, 6). Patients with TSS incurred significant healthcare costs, $36,656 per hospitalization on average-over thrice as much as hospitalizations without a diagnosis of TSS, and a mean LOS nearly four times longer than patients without TSS. Significant sociodemographic factors that we found to be associated with TSS included female sex, 0-17 year age group and Asian race. Interestingly, Hispanic and black race/ethnicity, lower income quartiles and more numerous chronic conditions were all inversely associated with TSS. A previous case review (13) found that 87% of nonmenstruating and 98% of menstruating patients with TSS were white, which is an even greater proportion than the 72% of patients identified in the present study. Finally, age groups 40-59 and 60-79 years; black, Hispanic, and Asian race/ethnicity; Medicaid coverage; and more numerous chronic conditions were all associated with increased cost of care and LOS in patients with TSS. There were key differences in associations between TSS and septic shock, as well as staphylococcal versus streptococcal TSS, suggesting these are specific disease risk factors. Interestingly, the west region of the USA had a higher prevalence of TSS than the south, north-east or mid-west. These findings are similar to those of a previous study that found a high prevalence of TSS in the Pacific and Mountain regions of the USA (14) . The reasons for these geographic differences remain unclear.
Not surprisingly, infections were strongly associated with TSS in the current cohort. Several causes of infection were strongly associated with TSS hospitalization, including necrotizing fasciitis, septicemia, infectious arthritis, postpartum infection, endocarditis, any skin infection, pneumonia and urinary tract infections. Previous case analyses found sinusitis (15) , endocarditis (18) , postoperative infection (17) , cellulitis (18) , postpartum infection (19) , septic arthritis (20) , chickenpox (9, 21) , and viral influenza preceding the development of TSS; all of these were significantly associated with TSS in the present study.
The age-and sex-adjusted in-hospital mortality of TSS was 11.0%. Past studies have found varying mortality rates for TSS. A French study of patients (22) with TSS from 2003 to 2006 found 22% mortality in non-menstruating patients with TSS compared to 0% mortality in those who were menstruating. Previous surveillance data from the Centers for Disease Control and Prevention in 1979-1996 reported (13) only 3% mortality for menstruating patients with TSS compared with a 5% mortality for nonmenstruating patients. The present study found a lower mortality in patients with TSS and vaginal foreign bodies (4.3%), consistent with previous findings of a lower mortality in menstruation-associated TSS (13, 22) . Epidemiologic analyses of streptococcal TSS have found much higher mortality rates, from 30-80% (3, 7, 23, 24) . The design of the present study did not allow us to distinguish between TSS associated with Staphylococcus spp. or Streptococcus spp. in every documented case. However, we found that a concomitant diagnosis of any streptococcal infection was associated with greater mortality than a concomitant diagnosis of any staphylococcal infection, in agreement with previous findings (3, 7, 23, 24) . However, it is possible that the observed differences are attributable to differences in patient characteristics between the two diseases and to differences in the severity of the underlying infection.
In the present study, we found that one of the strongest predictors of mortality in patients with TSS is a concomitant diagnosis of respiratory failure. Other major predictors of increased mortality include chickenpox infection, older age, Asian and Black race, and concomitant diagnoses of any liver damage/disease or any coagulopathy. The dramatically greater mortality we identified in patients with varicella and TSS is consistent with a previous German nationwide laboratory-based surveillance study that reported that patients with underlying varicella had higher complication rates than those with invasive group A streptococcal infections (25) . Thus, patients with varicella who develop TSS may require closer monitoring and more aggressive treatment to prevent mortality. Universal varicella vaccination might prevent a subset of childhood streptococcal TSS cases and mortality; in the present study, we were unable to determine varicella vaccination status. Future studies involving serologic data could help elucidate the effects of positive vaccination titers on incidence of TSS.
While it is logical that concomitant organ failure would lead to higher disease mortality, the reasons behind associations with other characteristics are less clear. Previous studies of Staphylococcus aureus bacteremia have shown greater age and female sex to be significant predictors of increased mortality (26) . However, the specific roles of sociodemographic characteristics in TSS remain understudied, likely because of the rarity of this disease and small sample sizes. Further laboratory and prospective studies could help explain the racial disparities seen in TSS mortality.
This study has numerous strengths, including the analysis of a large, nationally representative sample of adults and children of all ages from all states of the USA and their socioeconomic statuses. We analyzed data on nearly 62 million hospitalizations, which enabled identification of over 4000 patients with TSS from 2003-2012. TSS is a severe illness, involving bacterial infection, hypotension and multiorgan dysfunction, and those affected are almost invariably admitted to a hospital for management, enabling epidemiological analysis using the NIS. Despite these strengths, this study also has numerous limitations. We identified TSS and the examined comorbidities by ICD-9-CM coding and did not verify them by chart review. Thus, milder cases of TSS may have gone unrecognized. Because we identified comorbidities by ICD-9 coding, we were unable to distinguish between menstruating and nonmenstruating patients disease or between staphylococcal and streptococcal TSS. Though a minority of cases had secondary diagnoses including vaginal foreign body, staphylococcal septicemia and streptococcal septicemia, these diagnoses were not available frequently enough to reliably distinguish between the different underlying causes of TSS. Further, the NIS does not contain data on treatments or medications used during hospitalization, so we were unable to determine the efficacy of any treatments. Finally, because this was a cross-sectional study, we were unable to determine causation, temporality of comorbidities or direction of association. It is possible that some of the examined comorbidities preceded diagnosis of TSS whereas other comorbidities were likely a result of underlying TSS; we were unable to differentiate between these possibilities. We were also unable to determine the characteristics of the foreign bodies in identified patients with this association. A previous study has shown that the strongest predictor of TSS in patients with vaginal foreign bodies was use of high-absorbency tampons in the 1980s (27) .
In conclusion, TSS poses a significant healthcare burden, with large costs of care and significantly longer LOS than inpatients without TSS. We identified several disparities in characteristics of patients with TSS hospitalization and mortality. In particular, younger age, female sex and Asian race were associated with significantly increased odds of TSS hospitalization, whereas Black and Hispanic race/ethnicity were associated with decreased odds. However, Asian, Black and Hispanic race/ethnicity were all associated with increased costs of care, LOS and higher mortality attributab;e to TSS than was White ethnicity. Finally, the strongest predictors of mortality from TSS were concomitant diagnoses of respiratory failure, any liver damage/disease, coagulopathy, and older age.
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